Cortellis Deals Intelligence
Pharmaceutical Deal Intelligence & Analytics Platform — The industry's largest and highest-quality deal database
Cortellis Deals Intelligence (CDI) is Clarivate's pharmaceutical deal intelligence and analytics platform, offering the industry's largest and highest-quality deal database. The platform integrates complete deal structures, SEC-filed contracts, AI predictive analytics, and enhanced visualization tools to support licensing, partnership, M&A, and venture funding decisions across the life sciences industry.
Trusted by 70% of the world's top licensors, CDI enables users to find the best partners, determine optimal timing for drug licensing, and secure the best deal terms for their assets. The platform is built on 35+ years of curated historical data, continuously maintained by 650+ chemists, biologists, and medically trained editors.
Cortellis Deals Intelligence — The industry's largest and highest-quality pharmaceutical deal database covering 104K+ deals and 194K+ company profiles
Data Coverage
Deals
The industry's largest deal database covering 35+ years of historical data
Contracts
Including 5,000+ unredacted SEC-filed contracts — a unique competitive advantage
Company Profiles
Global company profiles supporting partner identification and competitive analysis
Global Patents
Comprehensive patent information from 4,000,000+ patent families
Early-Stage Assets
Early-stage deal and asset tracking
Expert Team
Chemists, biologists, and medically trained editors with 4-7+ years of relevant experience
Core Features
Industry-Leading Deal Intelligence
Complete deal structures from SEC-filed contracts, full-text access to 5,000+ unredacted contracts. Smart summaries and standardized deal overviews with comprehensive financial terms (upfront payments, milestones, royalties)
Powerful Search Filters
Filter by therapeutic area, mechanism of action, technology, or development stage. Search across all deal types: licensing, M&A, co-development, venture funding
Summaries & Visualization
Export effective royalty rates with standardized comparisons. Enhanced deal overview visualization with financial data exportable to Excel with summary tables
AI Predictive Deal Analytics
Calculate potential deal size and upfront payments without manual analysis. AI algorithms more accurate than traditional static NPV models, with continuously updated data streams for market trend prediction
Robust Data Curation
Manual indexing and tagging based on industry-leading ontology. 650+ domain experts continuously monitoring and updating sources through manual and automated pipelines
Cross-Module Integration
Seamless connection with Cortellis Competitive Intelligence for R&D pipeline context, integrated with Clinical Trials and Drug Discovery Intelligence, with single sign-on (SSO) access
CDI Deal Overview Dashboard — Quick search, deal size analysis, and global top 10 company rankings
Deal Types Covered
Licensing (In/Out)
Drug/technology licensing deals with financial terms
Co-Development
Joint development agreements between companies
M&A
Full company mergers and asset acquisitions
Research Collaboration
Academic and industry research partnerships
Manufacturing / Supply
CMO/CDMO agreements, supply chain deals
Marketing / Distribution
Co-promotion, co-marketing agreements
Venture Funding
VC investments, Series A-D funding, IPOs
Asset Purchase
Individual asset/product acquisition deals
CDI Deal Trends — Analyze deal volume and trends by company to identify potential partners
Industry Validation
World's Top Licensors
Use Cortellis to inform their licensing deal decisions
U.S. NME-Submitting Companies
Supported by Cortellis intelligence
Breakthrough Therapy Designations
Companies receiving breakthrough therapy designations use Cortellis
Annual Tracked Deal Value
In 2020 alone, nearly 2,000 deals were tracked with a total value of approximately $200 billion
Industries & Users
| Industry | Primary Use Cases |
|---|---|
| Pharmaceutical Companies | Licensing strategy, partner identification, deal benchmarking, M&A due diligence |
| Biotech Companies | Out-licensing optimization, venture funding analysis, partner search |
| Investment Banks | Life sciences M&A advisory, deal valuation support |
| VC / Private Equity | Biotech investment analysis, venture funding tracking, portfolio evaluation |
| Management Consulting | Deal benchmarking, market landscape analysis |
| Generic Pharma | Market entry deals, ANDA-related licensing, supply agreements |
CDI Due Diligence — Complete deal structure, financial terms, timeline, and key event tracking
Related Products
Learn About Deals Intelligence
Find the best partners, determine optimal licensing timing, and secure the best deal terms for your assets
Contact Us